Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $1000.0000 (0%) ($0.0000 - $0.0000) on Wed. Apr. 11, 2007. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 44.41% (three month average) | RSI | 0 | Latest Price | $1000.0000(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 21.6% a day on average for past five trading days. | Weekly Trend | CAPR declines -7.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) LQD(3%) TLT(3%) XLP(3%) EWI(2%) EWP(2%) | Factors Impacting CAPR price | CAPR will decline at least -22.205% in a week (0% probabilities). GLD(-0%) FXI(0%) XLU(1%) XLK(1%) VWO(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -22.205% (StdDev 44.41%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $1261.22 | 5 Day Moving Average | $1125(-11.11%) | 10 Day Moving Average | $1211.54(-17.46%) | 20 Day Moving Average | $1261.22(-20.71%) | To recent high | -50% | To recent low | 700% | Market Cap | $19.698b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |